The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

Published:2014-07-31 Issue:3 Volume:22 Page:254-262
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Oze T.¹,Hiramatsu N.¹,Yakushijin T.¹,Yamada R.¹,Harada N.¹,Morishita N.¹,Oshita M.²,Mita E.³,Ito T.⁴,Inui Y.⁵,Inada M.⁶,Tamura S.⁷,Yoshihara H.⁸,Imai Y.⁹,Kato M.¹⁰,Miyagi T.¹,Yoshida Y.¹,Tatsumi T.¹,Kasahara A.¹¹,Hayashi N.¹²,Takehara T.¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Osaka University Graduate School of Medicine; Suita Osaka Japan

2. Osaka Police Hospital; Osaka City Osaka Japan

3. National Hospital Organization Osaka National Hospital; Osaka City Osaka Japan

4. Osaka Koseinenkin Hospital; Osaka City Osaka Japan

5. Hyogo Prefectural Nishinomiya Hospital; Nishinomiya Hyogo Japan

6. Toyonaka Municipal Hospital; Toyonaka Osaka Japan

7. Minoh City Hospital; Minoh Osaka Japan

8. Osaka Rosai Hospital; Sakai Osaka Japan

9. Ikeda Municipal Hospital; Ikeda Osaka Japan

10. National Hospital Organization Minami Wakayama Medical Center; Tanabe Wakayama Japan

11. Department of General Medicine; Osaka University Hospital; Suita Osaka Japan

12. Kansai Rosai Hospital; Amagasaki Hyogo Japan

Funder

Grant-in-Aid for Research on Hepatitis

Ministry of Health Labour and Welfare of Japan

Scientific Research from the Ministry of Education, Science and Culture of Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12289/fullpdf

Reference19 articles.

1. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

2. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection;McHutchison;N Engl J Med,2009

3. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hezode;N Engl J Med,2009

4. Telaprevir for previously treated chronic HCV infection;McHutchison;N Engl J Med,2010

5. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends in Non-Interferon-Based Genotype-Specific Antiviral Agents: Pharmaceutical Perspectives;Critical Reviews in Eukaryotic Gene Expression;2017

2. Risk Factors for Treatment Discontinuation Caused by Adverse Events When Using Telaprevir, Peginterferon, and Ribavirin to Treat Chronic Hepatitis C: A Real-World Retrospective Cohort Study;Biological & Pharmaceutical Bulletin;2017

3. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection;Hepatology Research;2016-10-26

4. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy;Journal of Medical Virology;2016-03-29

5. Antiviral Drugs;Side Effects of Drugs Annual;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3